Scientia Vascular Acquired by Medtronic — Healthcare M&A

Medtronic plc has entered into a definitive agreement to acquire Scientia Vascular, Inc. in a transaction valued at $550 million. The deal is structured as a merger, with Medtronic, a public medical technology company, as the acquirer. The announcement places the transaction in the over-$100 million category, reflecting Medtronic’s continued focus on expanding its medical devices portfolio.

Scientia Vascular operates in the healthcare sector, developing technologies aimed at improving vascular care. For Medtronic, the acquisition supports efforts to strengthen its presence in vascular interventions and related treatment pathways, aligning with broader industry trends toward targeted, procedure-focused device innovation and portfolio expansion.

Specific closing conditions and timing were not provided in the available information. Financial details beyond the headline $550 million valuation were also not clearly delineated, but the agreement signals Medtronic’s intent to integrate Scientia Vascular’s capabilities into its existing medical devices platform following regulatory approvals and customary merger steps.